Pages

Sunday, March 13, 2022

Kinsale Capital Reaping The Benefits Of Excellence Of Execution

 

It’s early and hyperbolic to proclaim Kinsale Capital (KNSL) the best there is or will be in excess & surplus underwriting, but clearly management has figured out a winning formula, as Kinsale has managed to grow premiums at a compound rate of over 36% across the last four years, while growing underwriting income at close to 50% and continually posted modest positive reserve developments. Better still, the company is still a small fish in a big, growing pond, and I don’t see much that would impair Kinsale’s future growth rate.

Valuation is tricky and I won’t be surprised to see comments along the lines of “no way I’d ever pay 7x book”. Given double-digit core earnings growth potential, though, I don’t think Kinsale is necessarily overvalued, and the best-run companies have a way of making expensive-looking valuations look not-so-expensive with the benefit of hindsight (cf. W. R. Berkley (WRB)).

 

Click here to continue: 

Kinsale Capital Reaping The Benefits Of Excellence Of Execution

No comments:

Post a Comment